Study evaluates therapy optimization and system management of endovascular pulmonary neuromodulation in ADHF MINNEAPOLIS, May 19, 2022 /PRNewswire/ — Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce initial enrollment in their STIM-ADHF Study. The study will evaluate therapy optimization and system management of the Cardiac Pulmonary Nerve Stimulation (CPNS™) System in […]



